Hyperhomocysteinemia in children and adolescents with systemic lupus erythematosus: evolutive evaluation

Hyperhomocysteinemia in children and adolescents with systemic lupus erythematosus: evolutive evaluation

Alternative title Hiperhomocisteinemia em crianças e adolescentes com Lúpus Eritematoso Sistémico: avaliação evolutiva
Author Terreri, Maria Teresa Ramos Ascensão Autor UNIFESP Google Scholar
Sarni, Roseli Oselka Saccardo Autor UNIFESP Google Scholar
Prado, Rogerio do Autor UNIFESP Google Scholar
Nascif, Ana Karina Soares Autor UNIFESP Google Scholar
D'Almeida, Vania Google Scholar
Hilário, Maria Odete Esteves Autor UNIFESP Google Scholar
Institution Universidade Federal de São Paulo (UNIFESP)
Abstract Introduction: One of the mechanisms implicated in the pathogenesis of coronary heart disease in patients with juvenile systemic lupus erythematosus (SLE) is the hyperhomocysteinemia. Our aim was to follow patients with juvenile SLE and to identify the presence and the persistence of hyperhomocysteinemia.Methods: We studied 18 patients with juvenile SLE (median age 13.5 y). A survey of demographic and clinic data was performed based on patients records. The plasma homocysteine concentration was performed twice with a median interval of 1.5 years (1.3-2.5), and association with nutritional status, disease activity, renal involvement and use of methotrexate was sought. The plasma homocysteine concentration was also evaluated in 59 healthy controls, sex and age-matched to the patients.Results: Of the 18 patients with juvenile SLE, 16 (88.9%) were female and 13 (72.2%) had renal involvement. Five out of 18 patients (27.8%) persisted with increased concentration of plasma homocysteine (above the 90(th) percentile of the healthy group). The elevated concentration of homocysteine did not show statistically significant association neither with renal involvement (in the first dosage, p=0.676 and in the second, p=0.500), disease activity (in the first dosage, p=0.630 and in the second, p=0.182), overweight/obesity (in the first dosage, p=0.485 and in the second, p=0.288) nor with short stature (in the first dosage, p=0.202 and in the second, P=0.500).Conclusion: This study emphasizes the persistence of elevated concentration of homocysteine in some patients with juvenile SLE and the need for evaluations of therapeutic strategies and nutritional education aiming to reduce risk factors of cardiovascular disease.
Keywords juvenile systemic lupus erythematosus
homocysteine
cardiovascular disease
children
adolescents
Language Portuguese
Date 2008-01-01
Published in Acta Reumatologica Portuguesa. Alges: Publisaude-edicoes Medicas Lda, v. 33, n. 1, p. 57-62, 2008.
ISSN 0303-464X (Sherpa/Romeo, impact factor)
Publisher Publisaude-edicoes Medicas Lda
Extent 57-62
Origin http://www.actareumatologica.pt/article_download.php?id=317
Access rights Open access Open Access
Type Article
Web of Science ID WOS:000254555700006
URI http://repositorio.unifesp.br/11600/42092

Show full item record




File

Name: WOS000254555700006.pdf
Size: 78.57Kb
Format: PDF
Description:
Open file

This item appears in the following Collection(s)

Search


Browse

Statistics

My Account